Entering text into the input field will update the search result below

Ocugen partnered COVID shot retains immune memory for at least six months – study

Jun. 10, 2022 9:08 AM ETOcugen, Inc. (OCGN) StockBy: Dulan Lokuwithana, SA News Editor

India"s Covaxin Vaccine Administered In Harare

Tafadzwa Ufumeli/Getty Images News

A newly published study indicates that Covaxin, a coronavirus shot the U.S. biotech Ocugen (NASDAQ:OCGN) and India’s Bharat Biotech plan to introduce in North America, generated strong six-month-long immune memory to the COVID-19 virus and

Recommended For You

More Trending News

About OCGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
OCGN--
Ocugen, Inc.